newsfilter
← Latest News
Business Wire·

Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs

Robigo’s engineered microbes for combatting Sudden Death Syndrome in soybeans match the performance of commercially available chemistries at half the cost, targeting launch in 2028. The second product in